Von Willebrand factor as a biological sensor of blood flow to monitor percutaneous aortic valve interventions.
暂无分享,去创建一个
F. Mouquet | P. Legendre | P. Lenting | S. Susen | B. Jude | C. Delhaye | J. Goudemand | A. Rauch | D. Deplanque | B. Staels | G. Chinetti | C. Zawadzki | F. Juthier | N. Rousse | C. Banfi | A. Vincentelli | A. Godier | E. Van Belle | A. Dupont | G. Schurtz | D. Corseaux | E. Jeanpierre | C. Hurt | C. Caron | A. Elkalioubie
[1] P. Leprince,et al. Postprocedural Aortic Regurgitation in Balloon-Expandable and Self-Expandable Transcatheter Aortic Valve Replacement Procedures: Analysis of Predictors and Impact on Long-Term Mortality Insights From the FRANCE2 Registry , 2014, Circulation.
[2] Wei Li,et al. Hypertensive stretch regulates endothelial exocytosis of Weibel-Palade bodies through VEGF receptor 2 signaling pathways , 2013, Cell Research.
[3] R. Baliga. From clinical observation to mechanism--Heyde's syndrome. , 2013, The New England journal of medicine.
[4] B. Prendergast,et al. Standalone balloon aortic valvuloplasty: Indications and outcomes from the UK in the transcatheter valve era , 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[5] Dong Chen,et al. Indexes of von Willebrand factor as biomarkers of aortic stenosis severity (from the Biomarkers of Aortic Stenosis Severity [BASS] study). , 2013, The American journal of cardiology.
[6] C. Casari,et al. von Willebrand factor: the old, the new and the unknown , 2012, Journal of thrombosis and haemostasis : JTH.
[7] P. Pibarot,et al. Predictive factors, efficacy, and safety of balloon post-dilation after transcatheter aortic valve implantation with a balloon-expandable valve. , 2012, JACC. Cardiovascular interventions.
[8] C. Schlensak,et al. Acquired Von Willebrand syndrome is an early-onset problem in ventricular assist device patients. , 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[9] C. Solomon,et al. Acquired type 2A von Willebrand syndrome caused by aortic valve disease corrects during valve surgery. , 2011, British journal of anaesthesia.
[10] B. Carabello. Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery , 2011, Current cardiology reports.
[11] K. Kent,et al. Complications and outcome of balloon aortic valvuloplasty in high-risk or inoperable patients. , 2010, JACC. Cardiovascular interventions.
[12] M. Slaughter,et al. Acquired von Willebrand Syndrome in Patients With an Axial Flow Left Ventricular Assist Device , 2010, Circulation. Heart failure.
[13] N. Uriel,et al. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. , 2010, Journal of the American College of Cardiology.
[14] K. Kent,et al. COMPLICATIONS AND OUTCOMES OF BALLOON AORTIC VALVULOPLASTY IN HIGH-RISK OR INOPERABLE PATIENTS , 2010 .
[15] G. Golderer,et al. Analysis of von Willebrand factor multimers by simultaneous high- and low-resolution vertical SDS-agarose gel electrophoresis and Cy5-labeled antibody high-sensitivity fluorescence detection. , 2010, American journal of clinical pathology.
[16] Cheng-Zhong Zhang,et al. Mechanoenzymatic Cleavage of the Ultralarge Vascular Protein von Willebrand Factor , 2009, Science.
[17] N. Lamblin,et al. Functional Impairment of Von Willebrand Factor in Hypertrophic Cardiomyopathy: Relation to Rest and Exercise Obstruction , 2008, Circulation.
[18] Christoph Benk,et al. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[19] M. Cupa,et al. Recombinant activated factor VII efficacy and safety in a model of bleeding and thrombosis in hypothermic rabbits: a blind study , 2007, Journal of thrombosis and haemostasis : JTH.
[20] J. Dong. Cleavage of ultra‐large von Willebrand factor by ADAMTS‐13 under flow conditions , 2005, Journal of thrombosis and haemostasis : JTH.
[21] S. Susen,et al. Acquired von Willebrand syndrome in aortic stenosis. , 2003, The New England journal of medicine.
[22] A. Sala,et al. Proteolysis of von Willebrand Factor and Shear Stress–Induced Platelet Aggregation in Patients With Aortic Valve Stenosis , 2000, Circulation.
[23] P. V. van Genderen,et al. Acquired von Willebrand Syndrome: Data from an International Registry , 2000, Thrombosis and Haemostasis.
[24] A. Jatene,et al. Reversible pulmonary trunk banding with a balloon catheter: assessment of rapid pulmonary ventricular hypertrophy. , 2000, The Journal of thoracic and cardiovascular surgery.
[25] É. Fressinaud,et al. Screening for von Willebrand disease with a new analyzer using high shear stress: a study of 60 cases. , 1998, Blood.
[26] R. Nagel,et al. Shear stress enhances the proteolysis of von Willebrand factor in normal plasma. , 1994, Blood.
[27] S. Windecker,et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[28] S. Windecker,et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, European heart journal.
[29] W. Keeling,et al. Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery , 2011 .
[30] J. Chambers,et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[31] P. V. van Genderen,et al. HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY von Willebrand Factor Propeptide in Vascular Disorders: A Tool to Distinguish Between Acute and Chronic Endothelial Cell Perturbation , 1999 .